These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 10759290

  • 1. Treatment of diabetes in patients with severe obesity.
    Scheen AJ.
    Biomed Pharmacother; 2000 Mar; 54(2):74-9. PubMed ID: 10759290
    [Abstract] [Full Text] [Related]

  • 2. New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
    Scheen AJ, Ernest P.
    Diabetes Metab; 2002 Dec; 28(6 Pt 1):437-45. PubMed ID: 12522323
    [Abstract] [Full Text] [Related]

  • 3. Current management strategies for coexisting diabetes mellitus and obesity.
    Scheen AJ.
    Drugs; 2003 Dec; 63(12):1165-84. PubMed ID: 12790691
    [Abstract] [Full Text] [Related]

  • 4. Promising new approaches.
    Reasner CA.
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [Abstract] [Full Text] [Related]

  • 5. Management of obesity in NIDDM (non-insulin-dependent diabetes mellitus).
    Cheah JS.
    Singapore Med J; 1998 Aug; 39(8):380-4. PubMed ID: 9844503
    [Abstract] [Full Text] [Related]

  • 6. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction.
    Lee M, Aronne LJ.
    Am J Cardiol; 2007 Feb 19; 99(4A):68B-79B. PubMed ID: 17307059
    [Abstract] [Full Text] [Related]

  • 7. Management of blood glucose in type 2 diabetes mellitus.
    Ripsin CM, Kang H, Urban RJ.
    Am Fam Physician; 2009 Jan 01; 79(1):29-36. PubMed ID: 19145963
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic implications of diabetes in cardiovascular disease.
    Cherian B, Meka N, Katragadda S, Arora R.
    Am J Ther; 2009 Jan 01; 16(6):e51-9. PubMed ID: 19940606
    [Abstract] [Full Text] [Related]

  • 9. Metabolic syndrome and type 2 diabetes: can we stop the weight gain with diabetes?
    Joffe D, Yanagisawa RT.
    Med Clin North Am; 2007 Nov 01; 91(6):1107-23, ix. PubMed ID: 17964912
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of sibutramine and orlistat on obese, poorly-controlled type 2 diabetic patients.
    Chou KM, Huang BY, Fanchiang JK, Chen CH.
    Chang Gung Med J; 2007 Nov 01; 30(6):538-46. PubMed ID: 18350737
    [Abstract] [Full Text] [Related]

  • 11. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE.
    J Diabetes Complications; 2009 Nov 01; 23(2):143-52. PubMed ID: 18413192
    [Abstract] [Full Text] [Related]

  • 12. Weight gain during insulin therapy in patients with type 2 diabetes mellitus.
    Heller S.
    Diabetes Res Clin Pract; 2004 Sep 01; 65 Suppl 1():S23-7. PubMed ID: 15315867
    [Abstract] [Full Text] [Related]

  • 13. Combination of drugs in the management of diabetes mellitus.
    Das S.
    J Indian Med Assoc; 2002 Jul 01; 100(7):434, 436, 445-7. PubMed ID: 12674168
    [Abstract] [Full Text] [Related]

  • 14. The effects of orlistat in patients with diabetes: improvement in glycaemic control and weight loss.
    Rowe R, Cowx M, Poole C, McEwan P, Morgan C, Walker M.
    Curr Med Res Opin; 2005 Nov 01; 21(11):1885-90. PubMed ID: 16307710
    [Abstract] [Full Text] [Related]

  • 15. The effects of pharmacologic agents for type 2 diabetes mellitus on body weight.
    Pi-Sunyer FX.
    Postgrad Med; 2008 Jul 01; 120(2):5-17. PubMed ID: 18654064
    [Abstract] [Full Text] [Related]

  • 16. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
    Rosenberg DE, Jabbour SA, Goldstein BJ.
    Diabetes Obes Metab; 2005 Nov 01; 7(6):642-53. PubMed ID: 16219008
    [Abstract] [Full Text] [Related]

  • 17. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E, Minuto F, Colao A, Ferone D.
    Acta Diabetol; 2009 Jun 01; 46(2):85-95. PubMed ID: 19322513
    [Abstract] [Full Text] [Related]

  • 18. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G, Cicero AF, Murdolo G, Ciccarelli L, Fogari R.
    Diabetes Nutr Metab; 2004 Aug 01; 17(4):222-9. PubMed ID: 15575343
    [Abstract] [Full Text] [Related]

  • 19. Treatment modalities of obesity: what fits whom?
    Hainer V, Toplak H, Mitrakou A.
    Diabetes Care; 2008 Feb 01; 31 Suppl 2():S269-77. PubMed ID: 18227496
    [Abstract] [Full Text] [Related]

  • 20. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
    Harden KA, Cowan PA, Velasquez-Mieyer P, Patton SB.
    J Am Acad Nurse Pract; 2007 Jul 01; 19(7):368-77. PubMed ID: 17680902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.